Method and medicine for treating gastrointestinal disorder including fecal incontinence
OwnerJames Lundeeninventor
Life of this patent
Estimating the term…
Abstract
A method and a medicine for treating a human having a gastrointestinal disorder that includes fecal incontinence are provided. The method includes administering a dose of the medicine to the human. The medicine includes a tricyclic antidepressant and a stool softener.
Claims51
A method of treating a human having a gastrointestinal disorder comprising fecal incontinence, fecal urgency, or a combination thereof, the method comprising:
- administering a dose of a medicine to the human having the gastrointestinal disorder, the medicine comprising
- a tricyclic antidepressant, and
- a stool softener.
The method as defined in claim 9, wherein the tricyclic antidepressant is present in an efficacious amount in a range of less than 75 milligrams per day.
A medicinal composition for treating a human having a gastrointestinal disorder comprising fecal incontinence, fecal urgency, or a combination thereof, the composition comprising:
- a tricyclic antidepressant, and
- a stool softener.
A treatment kit for a human having a gastrointestinal disorder comprising fecal incontinence, the kit comprising:
- a plurality of doses of a medicine, the medicine comprising:
- a tricyclic antidepressant, and
- a stool softener comprising one or more of a surfactant and a fecal lubricant.
A process for treating a gastrointestinal disorder in a human, comprising:
- causing an interaction with muscarinic receptors in the human to reduce or eliminate fecal incontinence of a stool, fecal urgency, or both of the human, and
- delivering into fecal matter an oil and water by emulsification using a surfactant to soften the stool of the human,
- delivering into fecal matter a fecal lubricant to facilitate passage of the stool, or
- emulsifying and lubricating the fecal matter to both soften the stool and facilitate passage of the stool,
- wherein the emulsifying, lubricating, or emulsifying and lubricating occurs in the bowel of the human substantially simultaneously or temporally adjacent to the interaction with the muscarinic receptors.
Dependencies are inferred from the claim text.